Centessa Pharmaceuticals (CNTA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

16.460
+0.180+1.11%

Close Jan 24 16:00 ET

16.450
-0.010-0.06%

Post 17:27 ET

2.17BMarket Cap-10.83P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
BenzingaJan 24 05:03 ET
Is Centessa Pharmaceuticals Plc (CNTA) the Best Growth Stock to Buy Now Under $25?
Yahoo FinanceJan 9 17:14 ET
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Centessa Pharmaceuticals (CNTA)
TipRanksJan 9 09:10 ET · Ratings
Centessa Pharmaceuticals Updates on OX2R Agonist Pipeline
TipRanksJan 8 07:31 ET
Press Release: Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
Dow JonesJan 8 07:05 ET
TD Cowen Initiates Centessa Pharmaceuticals ADR at Buy
MT NewswiresJan 7 08:01 ET

Comments

Stock_Drift

Sep 26, 2024 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23, 2024 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22, 2024 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy